Imunon Inc expected to post a loss of $4.74 a share - Earnings Preview

Imunon

01/08/2025 14:17

Imunon Inc IMNN.OQ IMNN.O is expected to  show no change in quarterly revenue when it reports  results on August 5 for the period ending June 30 2025

​LSEG's mean analyst estimate for Imunon Inc is for a loss of $4.74 per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Imunon Inc is $135.00, about 93.9% above its last closing price of $8.29

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2025
-5.10
-5.25
-4.20
Beat
20
Dec. 31 2025
-5.18
-5.44
-5.25
Beat
3.4
Sep. 30 2024
-6.45
-5.96
-5.10
Beat
14.5​
Jun. 30 2024
-7.65
-8.15
-7.65
Beat
6.1
​​Mar. 31 2024
-8.46
-8.50
-7.80
Beat
8.2
Dec. 31 2023
-6.15
-7.80
Missed
-26.8​
Sep. 30 2023
-9.95
-9.90
-5.55
Beat
43.9
Jun. 30 2023
-10.57
-10.57
-9.15
Beat
13.5

This summary was machine generated August 1 at 13:17 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)